The Clorox Company
CLX
$107.94
$0.190.18%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -18.90% | 4.47% | -8.05% | -15.28% | 27.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.90% | 4.47% | -8.05% | -15.28% | 27.13% |
| Cost of Revenue | -12.87% | 4.01% | -11.56% | -14.80% | 13.40% |
| Gross Profit | -26.05% | 5.00% | -3.26% | -15.89% | 48.43% |
| SG&A Expenses | -8.07% | -15.19% | -5.54% | -5.47% | 11.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 600.00% | -50.00% | -175.00% | -55.56% | -114.29% |
| Total Operating Expenses | -10.82% | -3.08% | -10.14% | -12.00% | 11.97% |
| Operating Income | -59.39% | 47.87% | 6.64% | -31.18% | 295.95% |
| Income Before Tax | -39.55% | 49.09% | 704.76% | 74.26% | 510.34% |
| Income Tax Expenses | -66.22% | 37.04% | 687.50% | 7.50% | 1,750.00% |
| Earnings from Continuing Operations | -20.39% | 52.04% | 482.00% | 102.08% | 312.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 50.00% | 20.00% | -400.00% | 66.67% | -33.33% |
| Net Income | -19.19% | 53.70% | 464.71% | 107.53% | 350.00% |
| EBIT | -59.39% | 47.87% | 6.64% | -31.18% | 295.95% |
| EBITDA | -49.57% | 41.09% | 4.23% | -27.71% | 157.04% |
| EPS Basic | -18.42% | 55.11% | 467.28% | 108.23% | 350.54% |
| Normalized Basic EPS | -64.50% | 54.37% | 3.94% | -29.82% | 460.12% |
| EPS Diluted | -18.72% | 55.54% | 465.41% | 105.63% | 370.41% |
| Normalized Diluted EPS | -64.37% | 54.58% | 3.35% | -30.07% | 459.16% |
| Average Basic Shares Outstanding | -0.94% | -0.91% | -0.71% | -0.33% | -0.14% |
| Average Diluted Shares Outstanding | -1.33% | -1.05% | -0.15% | 0.03% | 0.02% |
| Dividend Per Share | 1.64% | 1.64% | 1.67% | 1.67% | 1.67% |
| Payout Ratio | 0.24% | -0.35% | 1.28% | -0.51% | -0.77% |